Amino terminus of apolipoprotein B suffices to produce recognition of malondialdehyde-modified low density lipoprotein by the scavenger receptor of human monocyte-macrophages

Journal of Lipid Research

Volumn 38, Issue 2, 1997, Pages 324-342

  Kreuzer, Jörg ^a,d   White, Ann L ^b,e   Knott, Timothy J ^b,f   Jien, Ming Len ^a   Mehrabian, Margarete ^a   Scott, James ^b,g   Young, Stephen G ^c   Haberland, Margaret E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MRC Clinical Research Centre   (United Kingdom)

^c GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^f Amersham Biosciences   (United States)

^g HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

apoB fusion protein; carboxyl truncated apoB 100; malondialdehyde LDL; scavenger receptor

Indexed keywords

APOLIPOPROTEIN B100; CELL RECEPTOR; LOW DENSITY LIPOPROTEIN; MACROPHAGE SCAVENGER RECEPTOR; MALONALDEHYDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; FLUORESCENCE MICROSCOPY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

EID: 0030972964     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. 100: genetic disorders associated with apolipoprotein B. Curr. Opin. Lipidol. 1: 104-109.
2. Haberland, M. E., and U. P. Steinbrecher. 1992. Modified low-density lipoproteins: Diversity and biological relevance in atherogenesis. In Molecular Genetics of Coronary Artery Disease A. J. Lusis, J. L. Rotter, and R. S. Sparkes, editors Vol. 14. Karger, Basel. 35-61.
3. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337.
4. Fogelman, A. M., I. Shechter, J. Seager, M. Hokom, J. S. Child, and P. A. Edwards. 1980. Malondialdehyde alteration of low density lipoprotein leads to cholesteryl ester accumulation in human monocyte macrophages. Proc. Natl. Acad. Sci. USA. 77: 2214-2218.
5. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
6. Berliner, J., M. Navab, A. Fogelman, J. Frank, L. Demer, P. Edwards, A. Watson, and A. Lusis. 1995. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 91: 2488-2496.
7. Kodama, T., M. Freeman, L. Rohrer, J. Zabrecky, P. Matsudaira, and M. Kreiger. 1990. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature. 343: 532-535.
8. Rohrer, L., M. Freeman, T. Kodama, M. Penman, and M. Krieger. 1990. Coiled-coil fibrous domains mediate binding by the macrophage scavenger receptor type II. Nature. 343: 570-572.
9. Krieger, M., S. Acton, J. Ashkenas, A, Pearson, M. Penman, and D. Resnick. 1993. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268: 3456-3554.
10. Fraser, I., D. Hughes and S. Gordon. 1993. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature. 364: 343-346.
11. el Khoury, J., C. A. Thomas, J. D. Loike, S. E. Hickman, L. Cao, and S. C. Silverstein. 1994. Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J. Biol. Chem. 269: 10197-10200.
12. Pearson, A., A. Rich, and M. Krieger. 1993. Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices. J. Biol. Chem. 268: 3546-3554.
13. Steinbrecher, U. P., M. Lougheed, W. C. Kwan, and M. Dirks. 1989. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem. 264: 15216-15223.
14. Zhang, H., Y. Yang, and U. Steinbrecher. 1993. Structural requirements for the binding of modified proteins to the scavenger receptor of macrophages. J. Biol. Chem. 268: 5535-5542.
15. Alaiz, M., M. Beppu, K. Ohishi, and K. Kikugawa. 1994. Modification of delipidated apoprotein B of low density lipoprotein by lipicl oxidation products in relation to macrophage scavenger receptor binding. Biol. Pharm. Bull. 17: 51-57.
16. Parthasarathy, S., L. G. Fong, D. Otero, and D. Steinberg. 1987. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. Proc. Natl. Acad. Sci. USA. 84: 537-540.
17. Freeman, M., Y. Ekkel, L. Rohrer, M. Penman, N. J. Freedman, G. M. Chisolm, and M. Krieger. 1991. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and non-reciprocal cross competition by acetylated and oxidized low density lipoprotein. Prof. Natl. Acad. Sci. USA. 88: 4931-4935.
18. Lougheed, M., and U. Steinbrecher. 1996. Mechanism of uptake of copper-oxidized low density lipoprotein in macrophages is dependent on its extent of oxidation. J. Biol. Chem. 271: 11798-11805.
19. Endemann, G., L. W. Stanton, K. S. Madden, C. M. Bryant, R. T. White, and A. A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811-11816.
20. Stanton, L. W., R. T. White, C. M. Bryant, A. A. Protter, and G. Endemann. 1992. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J. Biol. Chem. 267: 22446-22451.
21. Sambrano, G. R., S. Parthasarathy, and D. Steinberg. 1994. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 91: 3265-3269.
22. Palinski, W., Y.-H. S., M. E. Rosenfeld, S. W. Butler, S. A. Socher, S. Parthasarathy, L. K. Curtiss, and J. L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10: 325-335.
23. Haberland, M. E., A. M. Fogelman, and P. A. Edwards. 1982. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc. Natl. Acad. Sci. USA. 79: 1712-1716.
24. Haberland, M. E., C. L. Olch, and A. M. Fogelman. 1984. Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J. Biol. Chem. 259: 11305-11311.
25. Haberland, M. E., D. Fong, and L. Cheng. 1988. Malondialdehyde altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 241: 215-218.
26. Ylä-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
27. Fogelman, A., M. Haberland, J. Seager, M. Hokom, and P. Edwards. 1981. Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J. Lipid Res. 22: 1131-1141.
28. Brown, M. S., and J. L. Goldstein. 1983. Lipoprotein metabolisin in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52: 223-261.
29. Yao, Z., B. D. Blackhart, M. F. Linton, S. M. Taylor, S. G. Young, and B. J. McCarthy. 1991. Expression of carboxyl-terminally truncated forms of human apolipoprotein B in rat hepatoma cells. J. Biol. Chem. 266: 3300-3308.
30. Young, S., B. Bihain, L. Flynn, D. Sanan, M. Ayrault-Jarrier, and B. Jacotot. 1994. Asymptomatic homozygous hypolipoproteinemia associated with apolipoprotein B45.2. Hum. Molec. Gen. 3: 741-744.
31. Mehrabian, M., V. N. Schumaker, G. C. Fareed, R. West, D. F. Johnson, T. Kirchgessner, H.-C. Lin, X. Wang, Y. Ma, E. Mendiaz, and A. J. Lusis. 1985. Human apolipoprotein B: identification of cDNA clones and characterization of mRNA. Nucleic Acids Res. 13: 6937-6953.
32. Reue, K., D. Quon, K. O'Donnell, G. Dizikes, G. Fareed, and A. Lusis. 1984. Cloning and regulation of messenger RNA for mouse apolipoprotein E. J. Biol. Chem. 259: 2100-2107.
33. Innerarity, T. L., S. G. Young, K. S. Poksay, R. W. Mahley, R. S. Smith, R . W. Milne, Y. L. Marcel, and K. H. Weisgraber. 1987. Structural relationship of human apolipoprotein B48 to apolipoprotein B100. J. Clin Invest. 80: 1794-1798.
34. Fogelman, A. M., F. Elahi, K. Stykes, B. J. Van Lenten, M. C. Territo, and J. A. Berliner. 1988. Modification of the Recalde method for the isolation of human monocytes. J. Lipid Res. 29: 1243-1247.
35. Pullinger, C. R., J. D. North, B. B. Teng, V. A. Rifici, A. E. R. de Brito, and J. Scott. 1989. The apolipoprotein B gene is constitutively expressed in HepG2 cells: measurement of the mRNA half-life. J. Lipid Res. 30: 1065-1077.
36. Graham, D. L., T. J. Knott, T. C. Jones, R. J. Pease, C. R. Pullinger, and J. Scott. 1991. Carboxyl terminal truncation of apolipoprotein B results in gradual loss of the ability to form buoyant lipoproteins in cultured human and rat liver cell lines. Biochemistry. 30: 5616-5621.
37. Havel, R., H. Eder, and J. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
38. Pitas, R. E., T. L. Innerarity, J. N. Weinstein, and R. W. Mahley. 1981. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis. 1: 177-185.
39. McCormick, S., M. Linton, H. Hobbs, S. Taylor, L. Curtiss, and S. Young. 1994. Expression of human apolipoprotein B90 in transgenic mice. J. Biol. Chem. 269: 24284-24289.
40. Cardin, A, D., K. R. Witt, J. Chao, H. S. Margolius. V. H. Donaldson, and R. L. Jackson. 1984. Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins. J. Biol. Chem. 259: 8522-8528.
41. Knott, T. J., R. J. Pease, L. M. Powell, S. C. Wallis, S. C. J. Rall, T. L. Innerarity, B. Blackhart, W. H. Taylor, Y. Marcel, R. Rilne, D. Johnson, M. Fuller, A. J. Lusis, B. J. McCarthy, R. W. Mahley, B. Levy-Wilson, and J. Scott. 1986. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature. 323: 734-738.
42. Knott, T. J., S. C. Wallis, L. M. Powell, R. J. Pease, A. J. Lusis, B. Blackhart, B. J. McCarthy, R. W. Mahley, B. Levy-Wilson, and J. Scott. 1986. Complete cDNA and derived protein sequence of human apolipoprotein B-100. Nucleic Acids Res. 14: 7501-7503.
43. Ginsburg, G. S., M. T. Walsh, D. M. Small, and D. Atkinson. 1984. Reassembled plasma low density lipoproteins. J. Biol. Chem. 259: 6667-6673.
44. Ginsburg, G. S., D. M. Small, and D. Atkinson. 1982. Microemulsions of phospholipids and cholesterol esters. J. Biol. Chem. 257: 8216-8227.
45. McFarlane, A. S. 1958. Efficient trace-labelling of proteins with iodine. Nature (Lond.). 182: 53-57.
46. Bilheimer, D. W., S. Eisenberg, and R. I. Levy. 1972. The metabolism of very low density lipoprotein proteins. Biochim. Biophys. Acta. 260: 212-221.
47. Curtiss, L. K., and T. S. Edgington. 1982. Immunochemical heterogeneity of human plasma apolipoprotein B. J. Biol. Chem. 257: 15213-15221.
48. Lowry, O., H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
49. Goldstein, J. L., and M. S. Brown. 1974. Binding and degradation of low density lipoproteins by cultured human fibroblasts: comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J. Biol. Chem. 249: 5153-5162.
50. Stephan, Z. E., and E. C. Yuracheck. 1993. Rapid fluorometric assay of LDL receptor activity of DiI-labeled LDL. J. Lipid Res. 34: 325-330.
51. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
52. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76: 4350-4354.
53. Reue, K., D. Purcell-Huynh, M. Doolittle, A. Durstenfeld, and A. Lusis. 1993. Genetic variation in mouse apolipoprotein A-IV expression is determined pre- and post-transcriptionally. J. Lipid Res. 34: 893-903.
54. Lee, L. T., M. Lefevre, L. Wong, P. S. Roheim, and J. J. Thompson. 1987. Gradient acrylamide/agarose gels for electrophoretic separation of intact human very low density lipoproteins, intermediate density lipoproteins, lipoprotein [a], and low density lipoproteins. Anal. Biochem. 162: 420-426.
55. Lefevre, M., J. C. Goudey-Lefevre, and P. S. Roheim. 1987. Gradient gel electrophoresis-immunoblot analysis (GGEI): a sensitive method for apolipoprotein profile determinations. J. Lipid Res. 28: 1495-1507.
56. Weisgraber, K. H., T. L. Innerarity, and R. W. Mahley. 1978. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J. Biol. Chem. 253: 9053-9062.
57. White, A. L., D. L. Graham, J. LeGross, R. J. Pease, and J. Scott. 1992. Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. J. Biol. Chem. 267: 15657-15664.
58. Pitas, R. E., T. L. Innerarity, and R. W. Mahley. 1983. Foam cells in explants of atherosclerotic rabbit aortas have receptors for β-very low density lipoproteins and modified low density lipoproteins. Arteriosclerosis. 3: 2-12.
59. Powell, L. M., S. C. Wallis, R. J. Pease, Y. H. Edwards, T. J. Knott, and J. Scott. 1987. A novel form of tissue specific RNA processing produces apolipoprotein B48 in intestine. Cell. 50: 831-840.
60. Borén, J., L. Graham, M. Wettesten, J. Scott, A. White, and S-O. Olofsson. 1992. The assembly and secretion of apoB-100-containing lipoproteins in HepG2 cells. J. Biol. Chem. 267: 9858-9867.
61. Zawadzki, Z., R. W. Milne, and Y. L. Marcel. 1989. An immunochemical marker of low density lipoprotein oxidation. J. Lipid Res. 30: 885-891.
62. Galeano, N., R. Milne, Y. Marcel, M. Walsh, E. Levy, T. Ngu'yen, A. Gleeson, Y. Arad, L. Witte, M. Al-Haideri, S. Rumsey, and R. Deckelbaum. 1994. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J. Biol. Chem. 269: 511-519.
63. Kunitake, S., S. Young, G. Chen, C. Pullinger, S. Zhu, R. Pease, J. Scott, P. Hass, J. Schilling, and J. Kane. 1990. Conformation of apolipoprotein B-100 in the low density lipoproteins of Tangier disease. Identification of localized conformational response to triglyceride content. J. Biol. Chem. 265: 20739-20746.
64. McKeone, B., J. Patsch, and H. Pownall. 1993. Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells. J. Clin. Invest. 91: 1926-1933.
65. Gabelli, C. 1992. The lipoprotein metabolism of apolipoprotein B mutants. Curr. Opin. Lipidol. 3: 208-214.
66. Hardman, D., C. Pullinger, R. Hamilton, J. Kane, and M. Malloy. 1991. Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia. J. Clin. Invest. 88: 1722-1729.
67. Milne, R., R. Theolis, Jr., R. Maurice, R. J. Rease, P. K. Weech, E. Rassart, J. C. Fruchart, J. Scott, and Y. L. Marcel. 1989. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J. Biol. Chem. 264: 19754-19760.
68. Young, S., R. Koduri, R. Austin, R. Bonnet, R. Smith, and L. Curtiss. 1994. Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47. J. Lipid Res. 35: 399-407.
69. Young, S., F. Peralta, B. Dubois, L. Curtiss, J. Boyles, and J. Witztum. 1987. Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B100, does not bind to the apolipoprotein B,E (low density lipoprotein) receptor. J. Biol. Chem. 262: 16604-16611.
70. Segrest, J., M. Jones, V. Mishra, G. Anantharamaiah, and D. Garber. 1994. ApoB-100 has a pentapartite structure composed of three amphipathic α-helical domains alternating with two amphipathic β-strand domains. Arterioscler. Thromb. 14: 1674-1685.
71. Chen, S. H., C. Y. Yang, P. F. Chen, D. Setzer, M. Tanimura, W. H. Li, A. M. Gotto, Jr., and L. Chan. 1986. The complete cDNA and amino acid sequence of human apolipoprotein B-100. J. Biol. Chem. 261: 12918-12921.
72. Weisgraber, K. H., and S. C. J. Rall. 1987. Human apolipoprotein B-100 heparin-binding sites. J. Biol. Chem. 262: 11097-11103.
73. Yang, C., Z. W. Gu, M. Yang, and A. M. J. Gotto. 1994. Primary structure of apoB-100. Chem. Phys. Lipids. 67-68: 99-104.
74. Chou, P. Y., and G. D. Fasman. 1978. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 47: 45-148.
75. Steinbrecher, U. P. 1987. Oxidation of human low density lipoproteins results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262: 3603-3608.
76. Haberland, M. E., and A. M. Fogelman. 1985. Scavenger receptor-mediated recognition of maleyl bovine plasma albumin and the demaleylated protein in human monocyte macrophages. Proc. Natl. Acad. Sci. USA. 82: 2693-2697.
77. Brown, M. S., S. K. Basu, J. R. Falck, Y. K. Ho, and J. L. Goldstein. 1980. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively charged LDL by macrophages. J. Supramol. Struct. 13: 67-81.
78. Shih, I. L., R. S. Lees, M. Y. Chang, and A. M. Lees. 1990. Focal accumulation of an apolipoprotein B-based oligopeptide in the healing rabbit wall. Proc. Natl. Acad. Sci. USA. 87: 1436-1440.
79. Sivaram, P., S. Y. Choi, L. K. Curtiss, and I. J. Goldberg. 1994. An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells. J. Biol. Chem. 269: 9409-9412.
80. Sivaram, P., T. Vanni-Reyes, and I. Goldberg. 1996. Endothelial cells synthesize and process apolipoprotein B. J. Biol. Chem. 271: 15261-15266.
81. Bucala, R., R. Mitchell, K. Arnold, T. Innerarity, H. Vlassara, and A. Cerami. 1995. Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor. J. Biol. Chem. 270: 10828-10832.